The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 4361-4369
Abstract
Background: Stroke-associated pneumonia (SAP) is a standout complication after acute ischemic stroke (AIS), with a prevalence of 7– 38%. The aim of this prospective study was to investigate the relationship between serum YKL-40 levels at admission and SAP. Methods: Between August 2020 and February 2021, consecutive AIS patients from two centers were enrolled prospectively. Serum YKL-40 concentrations were measured via enzyme-linked immunosorbent assay. We performed logistic regression analyses to explore the relationship between YKL-40 and SAP. Receiver operating characteristic curve was also used to assess the predictive ability of YKL-40 in predicting SAP. Results: Ultimately, a total of 511 AIS patients were recruited. Multivariate logistic regression analysis showed that YKL-40 was independently related to SAP, whether as a continuous variable or as quartiles (P=0.001). The area under curve of YKL-40 to predict SAP was 0.765. The optimal cutoff value of YKL-40 as a predictor of SAP was determined to be 206.4 ng/mL, where the sensitivity was 63.1% and the specificity was 82.0%. Conclusion: Our study demonstrated that YKL-40 might be considered as a useful biomarker to predict SAP in AIS patients.Keywords
This publication has 33 references indexed in Scilit:
- Diagnosis of Stroke-Associated PneumoniaStroke, 2015
- Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhageClinical Biochemistry, 2014
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet, 2014
- Novel Risk Score to Predict Pneumonia After Acute Ischemic StrokeStroke, 2013
- Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke PatientsPLOS ONE, 2012
- Proteomic Biomarker Discovery in Cerebrospinal Fluid for Cerebral Vasospasm Following Subarachnoid HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2012
- YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patientsDiabetes Research and Clinical Practice, 2011
- Neural injury following stroke: are Toll‐like receptors the link between the immune system and the CNS?British Journal of Pharmacology, 2010
- Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in miceJournal of Neuroinflammation, 2008
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993